LitePharmTech Co., Ltd.
Quick facts
Phase 3 pipeline
- Atropine Sulfate 01 · Emergency Medicine, Anesthesia, Ophthalmology, Toxicology
Atropine sulfate is an anticholinergic agent that blocks muscarinic acetylcholine receptors to inhibit parasympathetic nervous system activity. - Atropine Sulfate 02 · Emergency Medicine, Ophthalmology, Cardiology
Atropine sulfate is an anticholinergic agent that blocks muscarinic acetylcholine receptors to inhibit parasympathetic nervous system activity. - Atropine Sulfate 03 · Emergency Medicine, Ophthalmology, Cardiology
Atropine sulfate is an anticholinergic agent that blocks muscarinic acetylcholine receptors to inhibit parasympathetic nervous system activity.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about LitePharmTech Co., Ltd.
What is LitePharmTech Co., Ltd.'s pipeline?
LitePharmTech Co., Ltd. has 3 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Atropine Sulfate 01, Atropine Sulfate 02, Atropine Sulfate 03.
Related
- Sector hub: All tracked pharma companies